Immunohematology Market Rises With Elderly Population Surge Is Supporting Development Across The Immunohematology Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Immunohematology Market Increase Between 2026 And 2030?

The immunohematology market has consistently expanded over recent years. This market is projected to expand from $2.56 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.9%. Historically, this growth has been fueled by factors such as the increasing prevalence of blood disorders, the growing demand for safe blood transfusions, the establishment of blood banks, the expansion of diagnostic laboratories, and innovations in hematology reagents.

The immunohematology market size is projected to experience substantial expansion over the coming years. It is anticipated to reach a valuation of $3.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.0%. This projected increase during the forecast period is largely driven by advancements in analyzer technology, the integration of artificial intelligence in lab diagnostics, the emergence of precision medicine, the incorporation of digital health systems, and the broadening scope of blood screening initiatives. Key developments expected in this period include sophisticated blood typing methods, increased automation in immunohematology assessments, tailored transfusion treatments, point-of-care immune diagnostic solutions, and the seamless integration of laboratory information systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What Key Growth Drivers Are Influencing The Immunohematology Market?

The immunohematology market is expected to expand moving forward, driven by the aging population. This demographic situation is defined by a growing proportion of older individuals within a society or population. Immunohematology is crucial for addressing age-related transfusion requirements, ensuring the safe application of blood products, and supporting medical procedures for the elderly demographic. For example, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, reported that the population of Americans aged 65 and older is anticipated to climb from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Over the same period, this age group’s proportion of the overall population is also projected to increase from 17% to 23%. Therefore, the aging population is a significant factor propelling the growth of the immunohematology market.

What Are The Major Segment Categories Within The Immunohematology Market?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Trends Are Influencing The Future Of The Immunohematology Market?

Key companies within the immunohematology market are dedicating efforts to developing innovative diagnostic solutions, such as soluble recombinant proteins designed to counteract the interference caused by the cancer therapy daratumumab. A soluble recombinant protein is one generated via recombinant DNA technology, which maintains its correct folding and functionality in a soluble form within a host cell or solution, thus aiding its use in both research and therapeutic applications. As an illustration, in November 2023, Grifols, S.A., a pharmaceutical company situated in Spain, introduced the Grifols sCD38 solution. Grifols’ sCD38 represents the first soluble recombinant protein ever, created to resolve the interference presented by the cancer treatment daratumumab in essential blood transfusion compatibility testing. This pioneering solution, specifically engineered for multiple myeloma patients, prevents daratumumab from binding to CD38 proteins on red blood cells, thereby ensuring accurate results for pre-transfusion tests. By facilitating a more efficient procedure for screening, identification, and crossmatching, Grifols sCD38 improves blood transfusion protocols and reduces delays in providing critical transfusions.

Which Companies Are Influencing The Immunohematology Market?

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Access The Complete Immunohematology Market Report:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Is The Dominant Market In The Immunohematology Market?

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Immunohematology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Browse Through More Reports Similar to the Global Immunohematology Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Immunodiagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795